Schedule 13G ownership disclosure

Menlo Therapeutics, Inc.

Security class unavailable · CUSIP: 586858102

Event date: 2018-01-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,243,168
Percent of class
5.4100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-18-009754
Form type
SC 13G
Filer
Yarrow Bioscience, Inc.
CIK
CIK 1566044
Filed
Feb 14, 2018
Reporting period
Jan 24, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub